8-K Announcements
6Material company update
Apr 29, 2026·SEC
Material company update
Apr 23, 2026·SEC
Material company update
Mar 12, 2026·SEC
Acadia Healthcare Company, Inc.(ACHC)Earnings, Financials & Key Ratios
ACHC•NASDAQ
$25.27
$2.33B mkt cap·Price updated May 6, 2026
AboutAcadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.Show more
- Revenue$3.31B+5.0%
- EBITDA$577M-14.1%
- Net Income-$1.1B-531.4%
- EPS (Diluted)-12.16-537.4%
- Gross Margin17.61%-22.0%
- EBITDA Margin17.42%-18.2%
- Operating Margin11.71%-29.3%
- Net Margin-33.29%-510.7%
- ROE-41.37%-591.9%
- ROIC5.9%-28.5%
- Debt/Equity1.24+89.8%
- Interest Coverage-6.68-269.5%
ACHC Key Insights
Acadia Healthcare Company, Inc. (ACHC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 85 (top 15%)
- ✓Trading at only 1.1x book value
✗Weaknesses
- ✗Profits declining 10.4% over 5 years
- ✗Negative free cash flow
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
ACHC Price & Volume
Acadia Healthcare Company, Inc. (ACHC) stock price & volume — 10-year historical chart
Loading chart...
ACHC Growth Metrics
Acadia Healthcare Company, Inc. (ACHC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years6.32%
5 Years9.65%
3 Years8.27%
TTM6.8%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-690.1%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-703.19%
Return on Capital
10 Years9.21%
5 Years9.67%
3 Years9.75%
Last Year7.47%
ACHC Recent Earnings
Acadia Healthcare Company, Inc. (ACHC) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
Apr 29, 2026EPS
$0.37
Est $0.28
+32.1%
Revenue
$829M
Est $824M
+0.6%
Q1 2026
Feb 25, 2026EPS
$0.07
Est $0.03
+133.3%
Revenue
$821M
Est $800M
+2.7%
Q4 2025
Nov 5, 2025EPS
$0.72
Est $0.68
+5.9%
Revenue
$852M
Est $848M
+0.4%
Q3 2025
Aug 5, 2025EPS
$0.83
Est $0.71
+16.9%
Revenue
$869M
Est $875M
-0.7%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 29, 2026 | $0.37vs $0.28+32.1% | $829Mvs $824M+0.6% |
| Q1 2026 | Feb 25, 2026 | $0.07vs $0.03+133.3% | $821Mvs $800M+2.7% |
| Q4 2025 | Nov 5, 2025 | $0.72vs $0.68+5.9% | $852Mvs $848M+0.4% |
| Q3 2025 | Aug 5, 2025 | $0.83vs $0.71+16.9% | $869Mvs $875M-0.7% |
Based on last 12 quarters of dataView full earnings history →
ACHC Peer Comparison
Acadia Healthcare Company, Inc. (ACHC) competitors in Hospitals and inpatient facilities — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 UHS | 10.35B | 165.40 | 7.16 | 9.71% | 8.56% | 20.65% | 8.2% | 0.74 |
 SEM | 2.04B | 16.44 | 13.93 | 5.12% | 2.42% | 6.57% | 18.77% | 1.82 |
 SGRY | 1.85B | 14.26 | -23.38 | 6.24% | -2.28% | -2.39% | 10.6% | 1.14 |
 BKD | 3.34B | 14.03 | -12.53 | 7.29% | -8.21% | -308.45% | 6.54% | |
 ENSG | 10.28B | 175.95 | 30.13 | 18.72% | 6.89% | 16.61% | 3.61% | 1.86 |
 HCA | 95.86B | 428.79 | 15.11 | 7.08% | 8.97% | 8.02% | ||
 THC | 16.37B | 186.91 | 12.07 | 3.12% | 7.94% | 19.56% | 15.45% | 1.47 |
 CYH | 397.43M | 2.82 | 0.75 | -1.18% | -0.41% | 52.34% |
Compare ACHC vs Peers
Acadia Healthcare Company, Inc. (ACHC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ACHC Income Statement
Acadia Healthcare Company, Inc. (ACHC) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 2.84B | 3.01B | 2.01B | 2.09B | 2.31B | 2.61B | 2.93B | 3.15B | 3.31B | 3.37B |
| Revenue Growth % | 0.9% | 6.21% | -33.33% | 4.06% | 10.74% | 12.79% | 12.2% | 7.69% | 5.04% | 6.8% |
| Cost of Goods Sold | 1.65B | 1.78B | 1.19B | 87.24M | 90.7M | 100.2M | 2.25B | 2.44B | 2.73B | 1.48B |
| COGS % of Revenue | 58.2% | 59.04% | 59.4% | 4.17% | 3.92% | 3.84% | 76.69% | 77.43% | 82.39% | - |
| Gross Profit | 1.19B▲ 0% | 1.23B▲ 4.1% | 815.49M▼ 33.9% | 2B▲ 145.6% | 2.22B▲ 11.0% | 2.51B▲ 12.9% | 682.61M▼ 72.8% | 711.98M▲ 4.3% | 583.44M▼ 18.1% | 1.89B▲ 0% |
| Gross Margin % | 41.8% | 40.96% | 40.6% | 95.83% | 96.08% | 96.16% | 23.31% | 22.57% | 17.61% | 56.21% |
| Gross Profit Growth % | 2.96% | 4.05% | -33.9% | 145.58% | 11.04% | 12.88% | -72.81% | 4.3% | -18.05% | - |
| Operating Expenses | 747.84M | 821.04M | 153.94M | 2B | 1.81B | 2.04B | 176.01M | 189.71M | 195.47M | 1.5B |
| OpEx % of Revenue | 26.37% | 27.25% | 7.66% | 95.83% | 78.17% | 78.24% | 6.01% | 6.01% | 5.9% | - |
| Selling, General & Admin | 273M | 307.71M | 153.94M | 1.31B | 1.42B | 1.6B | 176.01M | 189.71M | 195.47M | 1.14B |
| SG&A % of Revenue | 9.63% | 10.21% | 7.66% | 62.8% | 61.31% | 61.17% | 6.01% | 6.01% | 5.9% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -24.27M | -34.51M | 0 | 690.32M | 390.16M | 445.6M | 0 | 0 | 0 | 2M |
| Operating Income | 437.88M▲ 0% | 412.74M▼ 5.7% | 661.55M▲ 60.3% | 0▼ 100.0% | 414.47M▲ 0% | 467.69M▲ 12.8% | 506.6M▲ 8.3% | 522.28M▲ 3.1% | 387.96M▼ 25.7% | 393.31M▲ 0% |
| Operating Margin % | 15.44% | 13.7% | 32.94% | - | 17.91% | 17.92% | 17.3% | 16.56% | 11.71% | 11.67% |
| Operating Income Growth % | -1.63% | -5.74% | 60.28% | -100% | - | 12.84% | 8.32% | 3.1% | -25.72% | - |
| EBITDA | 580.89M | 571.58M | 749.48M | 437.16M | 521.19M | 585.46M | 638.95M | 671.87M | 577.21M | 587.95M |
| EBITDA Margin % | 20.48% | 18.97% | 37.32% | 20.92% | 22.52% | 22.43% | 21.82% | 21.3% | 17.42% | 17.44% |
| EBITDA Growth % | 0.11% | -1.6% | 31.12% | -41.67% | 19.22% | 12.33% | 9.13% | 5.15% | -14.09% | 3.48% |
| D&A (Non-Cash Add-back) | 143.01M | 158.83M | 87.92M | 95.26M | 106.72M | 117.77M | 132.35M | 149.59M | 189.25M | 194.64M |
| EBIT | 437.88M | 251.93M | 314.09M | 341.9M | 352.75M | 443.9M | 56.77M | 458.25M | -927.08M | -885.89M |
| Net Interest Income | -176.01M | -184.53M | -187.32M | -158.1M | -76.99M | -69.76M | -82.13M | -116.37M | -138.86M | -148.01M |
| Interest Income | 0 | 876K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 176.01M | 185.41M | 187.32M | 158.1M | 76.99M | 69.76M | 82.13M | 116.37M | 138.86M | 148.01M |
| Other Income/Expense | -201.08M | -581.7M | -583.16M | 183.8M | -138.71M | -93.55M | -531.96M | -180.4M | -1.45B | -1.46B |
| Pretax Income | 236.8M▲ 0% | -168.95M▼ 171.3% | 78.39M▲ 146.4% | 183.8M▲ 134.4% | 275.76M▲ 50.0% | 374.14M▲ 35.7% | -25.36M▼ 106.8% | 341.88M▲ 1448.1% | -1.07B▼ 411.8% | -1.07B▲ 0% |
| Pretax Margin % | 8.35% | -5.61% | 3.9% | 8.79% | 11.92% | 14.33% | -0.87% | 10.84% | -32.18% | -31.69% |
| Income Tax | 37.21M | 6.53M | 25.09M | 40.61M | 67.56M | 94.11M | -9.7M | 77.39M | 25.98M | 28.08M |
| Effective Tax Rate % | 15.71% | -3.87% | 32% | 22.09% | 24.5% | 25.15% | 38.25% | 22.64% | -2.44% | -2.63% |
| Net Income | 199.84M▲ 0% | -175.75M▼ 187.9% | 108.92M▲ 162.0% | -672.13M▼ 717.1% | 190.63M▲ 128.4% | 273.14M▲ 43.3% | -21.67M▼ 107.9% | 255.61M▲ 1279.7% | -1.1B▼ 531.4% | -1.11B▲ 0% |
| Net Margin % | 7.05% | -5.83% | 5.42% | -32.16% | 8.24% | 10.46% | -0.74% | 8.1% | -33.29% | -32.84% |
| Net Income Growth % | 3153.05% | -187.95% | 161.98% | -717.07% | 128.36% | 43.28% | -107.93% | 1279.73% | -531.42% | -690.1% |
| Net Income (Continuing) | 199.59M | 57.49M | 53.31M | 143.19M | 208.2M | 280.03M | -15.66M | 264.48M | -1.09B | -1.1B |
| Discontinued Operations | 0 | 0 | 56.81M | -812.39M | -12.64M | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 22.42M | 28.81M | 0 | 0 | 65.39M | 88.26M | 105.69M | 117.12M | 191.59M | 209.98M |
| EPS (Diluted) | 2.30▲ 0% | -2.01▼ 187.4% | 1.24▲ 161.7% | -7.65▼ 716.9% | 2.10▲ 127.5% | 2.98▲ 41.9% | -0.24▼ 108.1% | 2.78▲ 1258.3% | -12.16▼ 537.4% | -12.18▲ 0% |
| EPS Growth % | 3185.71% | -187.39% | 161.69% | -716.94% | 127.45% | 41.9% | -108.05% | 1258.33% | -537.41% | -703.19% |
| EPS (Basic) | 2.30 | -2.01 | 1.24 | -7.65 | 2.15 | 3.05 | -0.24 | 2.79 | -12.16 | - |
| Diluted Shares Outstanding | 87.06M | 87.29M | 87.82M | 88.59M | 90.79M | 91.56M | 90.95M | 92.06M | 90.7M | 90.86M |
| Basic Shares Outstanding | 86.95M | 87.29M | 87.61M | 87.88M | 88.77M | 89.68M | 90.95M | 91.62M | 90.7M | 90.53M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
ACHC Balance Sheet
Acadia Healthcare Company, Inc. (ACHC) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 471.55M | 450.42M | 542.21M | 2.52B | 495.03M | 506.13M | 596M | 577.49M | 814.14M | 837.2M |
| Cash & Short-Term Investments | 67.29M | 50.51M | 99.53M | 378.7M | 133.81M | 97.65M | 100.07M | 76.31M | 133.24M | 158.47M |
| Cash Only | 67.29M | 50.51M | 99.53M | 378.7M | 133.81M | 97.65M | 100.07M | 76.31M | 133.24M | 158.47M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 344.97M | 318.09M | 321.06M | 297.08M | 304.45M | 353.74M | 429.53M | 421.98M | 545.16M | 547.73M |
| Days Sales Outstanding | 44.39 | 38.54 | 58.35 | 51.88 | 48.01 | 49.46 | 53.53 | 48.83 | 60.07 | 56.27 |
| Inventory | 4.79M | 5.05M | 4.08M | 4.85M | 4.79M | 5.09M | 5.3M | 5.65M | 5.69M | 5.93M |
| Days Inventory Outstanding | 1.06 | 1.04 | 1.25 | 20.3 | 19.26 | 18.53 | 0.86 | 0.85 | 0.76 | 1.46 |
| Other Current Assets | 75.23M | 45.96M | 90.19M | 1.81B | 17.69M | 10.6M | 25.01M | 32.2M | 83.04M | 68.24M |
| Total Non-Current Assets | 5.95B | 5.72B | 6.34B | 3.98B | 4.27B | 4.48B | 4.76B | 5.38B | 4.71B | 4.71B |
| Property, Plant & Equipment | 3.05B | 3.11B | 1.6B | 1.72B | 1.9B | 2.09B | 2.38B | 2.97B | 3.25B | 3.24B |
| Fixed Asset Turnover | 0.93x | 0.97x | 1.26x | 1.22x | 1.21x | 1.25x | 1.23x | 1.06x | 1.02x | 1.05x |
| Goodwill | 2.75B | 2.4B | 2.09B | 2.11B | 2.2B | 2.22B | 2.23B | 2.26B | 1.3B | 1.3B |
| Intangible Assets | 87.35M | 88.99M | 68.83M | 68.53M | 70.14M | 76.04M | 73.28M | 70M | 96.67M | 98.58M |
| Long-Term Investments | 13M | 60.52M | 0 | 0 | 0 | 0 | 0 | 8.8M | 21.6M | 21.6M |
| Other Non-Current Assets | 49.57M | 64.93M | 2.58B | 79.13M | 94.97M | 92.7M | 72.55M | 43.24M | 50.95M | 238M |
| Total Assets | 6.42B▲ 0% | 6.17B▼ 3.9% | 6.88B▲ 11.4% | 6.5B▼ 5.5% | 4.77B▼ 26.6% | 4.99B▲ 4.6% | 5.36B▲ 7.4% | 5.96B▲ 11.2% | 5.53B▼ 7.2% | 5.55B▲ 0% |
| Asset Turnover | 0.44x | 0.49x | 0.29x | 0.32x | 0.49x | 0.52x | 0.55x | 0.53x | 0.60x | 0.57x |
| Asset Growth % | 6.64% | -3.92% | 11.45% | -5.52% | -26.64% | 4.61% | 7.44% | 11.16% | -7.21% | 3.35% |
| Total Current Liabilities | 377.39M | 416.38M | 463.58M | 1.31B | 404.86M | 388.33M | 885.78M | 577.92M | 525.19M | 489.36M |
| Accounts Payable | 102.3M | 117.74M | 90.26M | 87.81M | 98.58M | 104.72M | 156.13M | 232.7M | 150.4M | 142.2M |
| Days Payables Outstanding | 22.62 | 24.16 | 27.62 | 367.4 | 396.68 | 381.48 | 25.37 | 34.78 | 20.11 | 42.8 |
| Short-Term Debt | 34.83M | 34.11M | 43.68M | 153.48M | 18.59M | 21.25M | 29.22M | 76.82M | 50.69M | 32.5M |
| Deferred Revenue (Current) | 31.34M | 32.15M | 1.9M | 35.95M | 30.37M | 6.65M | 2.17M | 1.69M | 2.81M | 10.99M |
| Other Current Liabilities | 108.86M | 111.89M | 148.69M | 744.61M | 0 | 0 | 512.74M | 808K | 132.66M | 0 |
| Current Ratio | 1.25x | 1.08x | 1.17x | 1.93x | 1.22x | 1.30x | 0.67x | 1.00x | 1.55x | 1.55x |
| Quick Ratio | 1.24x | 1.07x | 1.16x | 1.93x | 1.21x | 1.29x | 0.67x | 0.99x | 1.54x | 1.54x |
| Cash Conversion Cycle | 22.83 | 15.42 | 31.98 | -295.22 | -329.41 | -313.48 | 29.02 | 14.9 | 40.71 | 14.94 |
| Total Non-Current Liabilities | 3.47B | 3.42B | 3.91B | 3.29B | 1.78B | 1.7B | 1.59B | 2.19B | 2.86B | 2.89B |
| Long-Term Debt | 3.21B | 3.16B | 3.11B | 2.97B | 1.48B | 1.36B | 1.34B | 1.88B | 2.47B | 2.49B |
| Capital Lease Obligations | 0 | 0 | 85.64M | 84.03M | 116.84M | 116.43M | 111.7M | 101.83M | 132.68M | 444.19M |
| Deferred Tax Liabilities | 80.33M | 80.37M | 22.82M | 50.02M | 74.37M | 92.59M | 1.93M | 83.95M | 66.61M | 317.21M |
| Other Non-Current Liabilities | 166.43M | 154.27M | 696.3M | 188.73M | 110.5M | 125.03M | 129.22M | 122.3M | 190.89M | 657.52M |
| Total Liabilities | 3.85B | 3.84B | 4.37B | 4.6B | 2.19B | 2.09B | 2.47B | 2.77B | 3.39B | 3.38B |
| Total Debt | 3.24B | 3.19B | 3.26B | 3.26B | 1.64B | 1.53B | 1.51B | 2.09B | 2.65B | 2.67B |
| Net Debt | 3.17B | 3.14B | 3.16B | 2.88B | 1.5B | 1.43B | 1.41B | 2.01B | 2.52B | 2.51B |
| Debt / Equity | 1.25x | 1.35x | 1.30x | 1.71x | 0.63x | 0.53x | 0.52x | 0.65x | 1.24x | 1.24x |
| Debt / EBITDA | 5.58x | 5.59x | 4.35x | 7.45x | 3.14x | 2.61x | 2.36x | 3.10x | 4.60x | 4.54x |
| Net Debt / EBITDA | 5.46x | 5.50x | 4.21x | 6.59x | 2.89x | 2.45x | 2.21x | 2.99x | 4.37x | 4.37x |
| Interest Coverage | 2.49x | 1.36x | 1.68x | 2.16x | 4.58x | 6.36x | 0.69x | 3.94x | -6.68x | -5.99x |
| Total Equity | 2.6B▲ 0% | 2.36B▼ 9.0% | 2.51B▲ 6.1% | 1.9B▼ 24.2% | 2.58B▲ 36.0% | 2.9B▲ 12.3% | 2.89B▼ 0.5% | 3.19B▲ 10.5% | 2.14B▼ 32.9% | 2.17B▲ 0% |
| Equity Growth % | 18.75% | -8.98% | 6.07% | -24.18% | 35.98% | 12.32% | -0.46% | 10.5% | -32.92% | -54.84% |
| Book Value per Share | 29.81 | 27.06 | 28.53 | 21.44 | 28.45 | 31.69 | 31.75 | 34.66 | 23.60 | 23.86 |
| Total Shareholders' Equity | 2.57B | 2.33B | 2.51B | 1.9B | 2.52B | 2.81B | 2.78B | 3.07B | 1.95B | 1.96B |
| Common Stock | 871K | 874K | 877K | 880K | 890K | 899K | 913K | 918K | 905K | 908K |
| Retained Earnings | 428.57M | 252.82M | 361.75M | -310.39M | -119.75M | 153.39M | 131.72M | 387.33M | -765.84M | -761.74M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -374.12M | -462.38M | -414.88M | -371.37M | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 22.42M | 28.81M | 0 | 0 | 65.39M | 88.26M | 105.69M | 117.12M | 191.59M | 209.98M |
ACHC Cash Flow Statement
Acadia Healthcare Company, Inc. (ACHC) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 399.58M | 414.08M | 332.9M | 658.81M | 374.48M | 380.57M | 462.34M | 129.69M | 131.9M | 131.9M |
| Operating CF Margin % | 14.09% | 13.75% | 16.58% | 31.52% | 16.18% | 14.58% | 15.79% | 4.11% | 3.98% | - |
| Operating CF Growth % | 10.54% | 3.63% | -19.6% | 97.9% | -43.16% | 1.63% | 21.49% | -71.95% | 1.7% | 185.06% |
| Net Income | 199.59M | -175.49M | 110.12M | 140.26M | 195.56M | 280.03M | -15.66M | 264.48M | -1.09B | -1.11B |
| Depreciation & Amortization | 143.01M | 158.83M | 164.04M | 95.26M | 106.72M | 117.77M | 132.35M | 149.59M | 189.25M | 194.64M |
| Stock-Based Compensation | 23.47M | 22M | 17.31M | 0 | 37.53M | 29.64M | 32.29M | 37.11M | 31.71M | 30.99M |
| Deferred Taxes | 31.37M | -9.71M | 1.78M | 53.11M | 11.77M | 16.55M | -93.98M | 67.71M | 1.09M | 17.05M |
| Other Non-Cash Items | 20.38M | 382.06M | 70.41M | 207.06M | 66.4M | 5.94M | 400.71M | 16.68M | 1.01B | 1B |
| Working Capital Changes | -18.25M | 36.39M | -30.76M | 163.12M | -43.5M | -69.35M | 6.63M | -405.88M | -8.67M | 30.82M |
| Change in Receivables | -28.57M | -16.82M | -19.06M | 15.34M | 2.45M | -41.98M | -39.01M | -2.33M | -75.02M | -75.18M |
| Change in Inventory | 11.82M | 29.61M | 6.48M | 0 | -13.99M | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -10.11M | 26.05M | -21.35M | 77.99M | 6.16M | 5.17M | 17.4M | -420.89M | 14.88M | 48.53M |
| Cash from Investing | -336.53M | -360.96M | -201.14M | -281.84M | 1.02B | -305.83M | -397.22M | -736.48M | -547.58M | -424.55M |
| Capital Expenditures | -274.18M | -341.46M | -284.68M | -216.62M | -244.81M | -296.15M | -424.13M | -690.38M | -571.81M | -397.18M |
| CapEx % of Revenue | 9.67% | 11.34% | 14.17% | 10.36% | 10.58% | 11.34% | 14.48% | 21.89% | 17.26% | - |
| Acquisitions | -18.19M | -18.19M | -45.68M | 92K | 1.37B | -9.51M | -349K | -53.55M | 24.32M | 9.77M |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -44.16M | -1.31M | 31.83M | -56.97M | -269.58M | -174K | 27.26M | 7.46M | -90K | -37.14M |
| Cash from Financing | -60.07M | -67.33M | -61.63M | -51.5M | -1.64B | -110.9M | -62.7M | 583.02M | 472.61M | 309.83M |
| Debt Issued (Net) | -57.3M | -61.66M | -52.98M | -44.37M | -1.64B | -113.59M | -16.25M | 583.67M | 532.34M | 322.75M |
| Equity Issued (Net) | 0 | -3.41M | -2.22M | 0 | -5.73M | 0 | 0 | -8.55M | -50.03M | -3.15M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -3.46M | -3.41M | -1.65M | 0 | -5.73M | 0 | 0 | -8.55M | -50.03M | -3.15M |
| Other Financing | -2.77M | -2.27M | -6.42M | -7.13M | 5.58M | 2.69M | -46.45M | 7.9M | -9.69M | -9.76M |
| Net Change in Cash | 10.23M▲ 0% | -16.78M▼ 264.1% | 73.68M▲ 539.1% | 279.16M▲ 278.9% | -244.88M▼ 187.7% | -36.16M▲ 85.2% | 2.42M▲ 106.7% | -23.77M▼ 1080.5% | 56.94M▲ 339.6% | 67.24M▲ 0% |
| Free Cash Flow | 125.4M▲ 0% | 72.62M▼ 42.1% | 48.22M▼ 33.6% | 442.19M▲ 817.0% | 129.67M▼ 70.7% | 84.42M▼ 34.9% | 38.21M▼ 54.7% | -560.69M▼ 1567.5% | -439.91M▲ 21.5% | -215.22M▲ 0% |
| FCF Margin % | 4.42% | 2.41% | 2.4% | 21.16% | 5.6% | 3.23% | 1.3% | -17.78% | -13.28% | -6.38% |
| FCF Growth % | 132.2% | -42.09% | -33.6% | 816.99% | -70.68% | -34.89% | -54.74% | -1567.51% | 21.54% | 17.27% |
| FCF per Share | 1.44 | 0.83 | 0.55 | 4.99 | 1.43 | 0.92 | 0.42 | -6.09 | -4.85 | -4.85 |
| FCF Conversion (FCF/Net Income) | 2.00x | -2.36x | 3.06x | -0.98x | 1.96x | 1.39x | -21.34x | 0.51x | -0.12x | 0.19x |
| Interest Paid | 159.1M | 175.2M | 173.24M | 0 | 93.67M | 65.69M | 80.75M | 113.4M | 0 | 0 |
| Taxes Paid | 10.29M | 6.14M | 31.91M | 0 | 79.3M | 86.19M | 66.4M | 28.15M | 0 | 0 |
ACHC Key Ratios
Acadia Healthcare Company, Inc. (ACHC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 8.36% | -7.09% | 4.48% | -30.52% | 8.51% | 9.96% | -0.75% | 8.41% | -41.37% | -40.92% |
| Return on Invested Capital (ROIC) | 5.87% | 5.49% | 8.89% | - | 7.01% | 8.33% | 8.8% | 8.25% | 5.9% | 5.9% |
| Gross Margin | 41.8% | 40.96% | 40.6% | 95.83% | 96.08% | 96.16% | 23.31% | 22.57% | 17.61% | 56.21% |
| Net Margin | 7.05% | -5.83% | 5.42% | -32.16% | 8.24% | 10.46% | -0.74% | 8.1% | -33.29% | -32.84% |
| Debt / Equity | 1.25x | 1.35x | 1.30x | 1.71x | 0.63x | 0.53x | 0.52x | 0.65x | 1.24x | 1.24x |
| Interest Coverage | 2.49x | 1.36x | 1.68x | 2.16x | 4.58x | 6.36x | 0.69x | 3.94x | -6.68x | -5.99x |
| FCF Conversion | 2.00x | -2.36x | 3.06x | -0.98x | 1.96x | 1.39x | -21.34x | 0.51x | -0.12x | 0.19x |
| Revenue Growth | 0.9% | 6.21% | -33.33% | 4.06% | 10.74% | 12.79% | 12.2% | 7.69% | 5.04% | 6.8% |
ACHC SEC Filings & Documents
Acadia Healthcare Company, Inc. (ACHC) SEC filings — annual & quarterly reports (10-K, 10-Q)
ACHC Frequently Asked Questions
Acadia Healthcare Company, Inc. (ACHC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Acadia Healthcare Company, Inc. (ACHC) reported $3.37B in revenue for fiscal year 2025. This represents a 1423% increase from $221.4M in 2011.
Acadia Healthcare Company, Inc. (ACHC) grew revenue by 5.0% over the past year. This is steady growth.
Acadia Healthcare Company, Inc. (ACHC) reported a net loss of $1.11B for fiscal year 2025.
Dividend & Returns
Acadia Healthcare Company, Inc. (ACHC) has a return on equity (ROE) of -41.4%. Negative ROE indicates the company is unprofitable.
Acadia Healthcare Company, Inc. (ACHC) had negative free cash flow of $215.2M in fiscal year 2025, likely due to heavy capital investments.
Explore More ACHC
Acadia Healthcare Company, Inc. (ACHC) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates